Design and Characterization of an Anti-Clec9a Antibody Armed with CpG Oligonucleotides To Enable Targeted Delivery of Adjuvant to Cross-Presenting Dendritic Cells
ACS Chemical Biology · 2025
DOI: 10.1021/acschembio.5c00318 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, 2025. Verfasst von Sayumi Yamazoe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bristol-Myers Squibb Research & Development, 700 Bay Road, Redwood City, California 94063, USA. Hauptthemen laut MEDLINE: Lectins, C-Type, Dendritic Cells, Oligodeoxyribonucleotides, Adjuvants, Immunologic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 88 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bristol-Myers Squibb Research & Development, 700 Bay Road, Redwood City, California 94063, USA.
ORCID-Profile: Sayumi Yamazoe
Zitieren
APA
Yamazoe, S., Sadanala, K., Zhang, Q., Rajpal, A., Sproul, T., Strop, P., & Broz, M. (2025). Design and Characterization of an Anti-Clec9a Antibody Armed with CpG Oligonucleotides To Enable Targeted Delivery of Adjuvant to Cross-Presenting Dendritic Cells. ACS Chemical Biology. https://doi.org/10.1021/acschembio.5c00318
Vancouver
Yamazoe S, Sadanala K, Zhang Q, Rajpal A, Sproul T, Strop P, et al. Design and Characterization of an Anti-Clec9a Antibody Armed with CpG Oligonucleotides To Enable Targeted Delivery of Adjuvant to Cross-Presenting Dendritic Cells. ACS Chemical Biology. 2025. doi:10.1021/acschembio.5c00318
BibTeX
@article{Yamazoe2025,
author = {Yamazoe, Sayumi and Sadanala, Keerthi and Zhang, Qian and Rajpal, Arvind and Sproul, Tim and Strop, Pavel and Broz, Miranda},
title = {Design and Characterization of an Anti-Clec9a Antibody Armed with CpG Oligonucleotides To Enable Targeted Delivery of Adjuvant to Cross-Presenting Dendritic Cells},
journal = {ACS Chemical Biology},
year = {2025},
doi = {10.1021/acschembio.5c00318}
}
EUVIMED